109 related articles for article (PubMed ID: 34057940)
1. Outcome of first relapse of Hodgkin lymphoma: single institution experience.
Shaheen N; Maaz AUR; Khan MS
J Pak Med Assoc; 2021 Mar; 71(3):883-888. PubMed ID: 34057940
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Refractory and Relapsed Hodgkin Lymphoma With Autologous Stem-Cell Transplantation: A Single Institution Experience.
Wali R; Saeed H; Patrus N; Javed S; Khan SJ
J Glob Oncol; 2019 Nov; 5():1-6. PubMed ID: 31756138
[TBL] [Abstract][Full Text] [Related]
3. Clinical course, long-term outcomes, and chemotherapy toxicity profile in B-cell Non-Hodgkin Lymphoma in children: Single institution experience of Pakistan.
Rehman P; Wali RM
J Pak Med Assoc; 2022 Oct; 72(10):1988-1993. PubMed ID: 36660986
[TBL] [Abstract][Full Text] [Related]
4. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
[TBL] [Abstract][Full Text] [Related]
5. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
[TBL] [Abstract][Full Text] [Related]
6. [Clinical pathologic characteristics and treatment outcomes of 19 relapsed pediatric B-cell lymphoma].
Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Ma XL; Zhang YH
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):748-753. PubMed ID: 29050112
[No Abstract] [Full Text] [Related]
7. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
[TBL] [Abstract][Full Text] [Related]
8. Impact of rituximab and IPI on survival in diffuse large B cell lymphoma patients treated at a tertiary level cancer centre in Pakistan: a single-centre experience.
Athar S; Siddiqui N; Rai SR; Muzaffar N; Hameed A
J Pak Med Assoc; 2015 Feb; 65(2):170-4. PubMed ID: 25842553
[TBL] [Abstract][Full Text] [Related]
9. Retrospective study of ovarian malignancy managed in surgical unit at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore.
Ali SI; Sayyed RH; Akbar SA; Abubakar M; Syed AA
J Pak Med Assoc; 2021 Feb; 71(2(B)):696-698. PubMed ID: 33941961
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of anaplastic large-cell lymphoma in children and adolescents: a retrospective multicenter survey study].
;
Zhonghua Er Ke Za Zhi; 2017 Mar; 55(3):194-199. PubMed ID: 28273702
[No Abstract] [Full Text] [Related]
11. Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma.
Krebs L; Amorin S; Brice P; Guillerm S; Menard J; Hennequin C; Quéro L
Strahlenther Onkol; 2017 Feb; 193(2):116-124. PubMed ID: 27316376
[TBL] [Abstract][Full Text] [Related]
12. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
[TBL] [Abstract][Full Text] [Related]
13. [The incidence and treatment of the first relapse in children with Hodgkin's disease].
Balwierz W; Moryl-Bujakowska A; Bogusławska-Jaworska J; Pisarek J; Raś M; Sońta-Jakimczyk D; Janik-Moszant A; Rokicka-Milewska R; Sopylo B; Kolakowska-Mrozowska B; Kołecki P; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Matysiak M; Newecka-Samól T
Med Wieku Rozwoj; 2000; 4(1 Suppl 2):73-84. PubMed ID: 12021465
[TBL] [Abstract][Full Text] [Related]
14. [Novel treatment options in relapsed and refracter Hodgkin lymphomas].
Illés Á; Jóna Á; Simon Z; Udvardy M; Miltényi Z
Orv Hetil; 2015 Nov; 156(45):1824-33. PubMed ID: 26522856
[TBL] [Abstract][Full Text] [Related]
15. Demographics and Outome in Paediatric Non-Hodgkin Lymphoma: Single Centre Experience at The Children Hospital Lahore, Pakistan.
Faizan M; Anwar S; Khan S
J Coll Physicians Surg Pak; 2018 Jan; 28(1):48-51. PubMed ID: 29290192
[TBL] [Abstract][Full Text] [Related]
16. Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and auto-SCT.
Akhtar S; Al-Sugair AS; Abouzied M; Alkadhi Y; Dingle M; Abdelsalam M; Soudy H; Darwish A; Eltigani A; Elhassan TA; Nabil-Ahmed M; Maghfoor I
Bone Marrow Transplant; 2013 Nov; 48(12):1530-6. PubMed ID: 23749108
[TBL] [Abstract][Full Text] [Related]
17. Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.
Nademanee A; Molina A; Dagis A; Snyder DS; O'Donnell MR; Parker P; Stein A; Smith E; Planas I; Kashyap A; Spielberger R; Fung H; Krishnan A; Bhatia R; Wong KK; Somlo G; Margolin K; Chow W; Sniecinski I; Vora N; Slovak M; Niland JC; Forman SJ
Clin Lymphoma; 2000 Jun; 1(1):46-54. PubMed ID: 11707813
[TBL] [Abstract][Full Text] [Related]
18. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy alone or combined chemotherapy and involved field radiotherapy in favorable risk early-stage classical Hodgkin lymphoma-a 10 years experience.
Ali S; Basit A; Kazmi AS; Sidhu A; Badar F; Hameed A
Pak J Med Sci; 2016; 32(6):1408-1413. PubMed ID: 28083035
[TBL] [Abstract][Full Text] [Related]
20. Long term survival and impact of various prognostic factors in T1, T2 oral tongue cancer in Pakistan.
Hussain R; Jamshed A; Iqbal H; Usman S; Irfan M; Hafeez Bhatti AB
J Pak Med Assoc; 2016 Feb; 66(2):187-93. PubMed ID: 26819166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
